ABVC - ABVC BioPharma GAAP EPS of -$0.52 revenue of $0.97M April, 03 2023 01:34 AM ABVC BioPharma Inc. 2023-04-03 01:34:38 ET ABVC BioPharma press release ( NASDAQ: ABVC ): FY GAAP EPS of -$0.52. Revenue of $0.97M (+169.4% Y/Y). For further details see: ABVC BioPharma GAAP EPS of -$0.52, revenue of $0.97M